Physical Activity, Cardiac and Skeletal Muscle Energetics in Healthy Subjects and HFpEF Patients
Part of paid clinical trials in Baltimore, Maryland.
- Sponsor
- Johns Hopkins University
- Study ID
- NCT04998877
- Status
- Active Not Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 85 Years
- Healthy Volunteers
- Accepted
Study Details
This research is being done to better understand the relationship between information collected by wearable devices and clinical measurements in people with heart failure with preserved ejection fraction (HFpEF) and others without HFpEF. This is an observational study with no study intervention or randomization. Participants will undergo baseline history and physical, 12-lead EKG, laboratory studies of blood/serum/urine, echocardiography, activity questionnaire, 6 minute walk test, and placement of wearable devices to be worn for up to 14 days (activity monitors, EKG monitor and continuous glucose monitor). Participants will return after \~14 days of wearing the devices and repeat of physical examination, 12-lead EKG, 6 minute walk test, activity questionnaire. Additionally, participants will undergo magnetic resonance imaging (MRI) of their leg with exercise, cardiopulmonary exercise testing (CPET) and, for those who qualify, magnetic resonance imaging (MRI) of their heart with exercise.
Key Dates
- Start date
- Aug 4, 2021
- Status verified
- Apr 2026
- Primary completion
- Jul 1, 2026
- Completion
- Jul 1, 2026
Study Design
- Enrollment
- 60 participants (estimated)
Arms
- Arm: Heart Failure with Preserved Ejection Fraction
- Arm: Healthy Volunteers
Primary Outcome Measure
Difference of daily activity measures based on accelerometry between HFpEF participants and adults without HFpEF. [ Time Frame: Up to 28 days ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Johns Hopkins Hosptial | Baltimore | Maryland | 21287 | - |
Find similar trials in Baltimore, MD
Related Studies
- Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure With Preserved Ejection FractionPHASE3 · Recruiting · Uppsala University · Alexander City, Alabama
- Myocardial Mechanisms in Heart Failure With Preserved Ejection FractionRecruiting · Northwestern University · Chicago, Illinois
- A Study of TX000045 in Patients With Pulmonary Hypertension Secondary to Heart Failure With Preserved Ejection Fraction (the APEX Study)PHASE2 · Recruiting · Tectonic Therapeutic · Phoenix, Arizona
- Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and ObesityPHASE3 · Recruiting · Amgen · Birmingham, Alabama